Scott Kelly
Company: CytoDyn
Job title: Chief Medical Officer
Seminars:
Driving Innovation in Patient Selection: Rethinking Inclusion & Exclusion Criteria 2:00 pm
Investigating clinical trials for NASH in HIV-infected patients Evaluating novel biomarker outcomes in NASH and considering comorbidities Beyond NASH: driving studies in cardiovascular and metabolic disordersRead more
day: Day 2 Stream 2 PM